Statements (45)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
muscle relaxant
|
| gptkbp:activeDuring |
methocarbamol
|
| gptkbp:availableIn |
generic
|
| gptkbp:brand |
gptkb:Robaxin
|
| gptkbp:chemicalFormula |
C11H15ClN2O2S
|
| gptkbp:clinicalTrials |
NCT00000123
NCT00000456 NCT00000789 |
| gptkbp:contraindication |
severe kidney disease
allergy to methocarbamol |
| gptkbp:date |
1957-01-01
|
| gptkbp:dosageForm |
1000 mg
750 mg |
| gptkbp:endOfLife |
1 to 2 hours
|
| gptkbp:formulation |
tablet
injection |
| gptkbp:gestationPeriod |
Category C
|
| gptkbp:healthcare |
store at room temperature
take with food keep out of reach of children do not exceed recommended dose do not drive after taking |
| https://www.w3.org/2000/01/rdf-schema#label |
Robaxin
|
| gptkbp:interactsWith |
alcohol
CNS depressants other muscle relaxants |
| gptkbp:legalStatus |
Prescription only
|
| gptkbp:mandates |
muscle pain
muscle strain muscle injury |
| gptkbp:manufacturer |
gptkb:Amgen
|
| gptkbp:numberOfStudents |
urine
|
| gptkbp:nutritionalValue |
liver
|
| gptkbp:operates_in |
M03BA03
|
| gptkbp:packaging |
bottle
vial |
| gptkbp:route |
oral
intravenous |
| gptkbp:sideEffect |
dizziness
nausea vomiting drowsiness blurred vision |
| gptkbp:usedFor |
muscle spasms
|
| gptkbp:weight |
248.77 g/mol
|